Efficacy and safety of tirofiban combined with intravenous thrombolysis in Acute ischemic stroke: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials and observational studies
{{output}}
Background: Acute ischemic stroke (AIS) is a leading cause of global morbidity and mortality. Tirofiban, a glycoprotein IIb/IIIa inhibitor, may enhance intravenous thrombolysis outcomes. Updated pooled data are needed to clarify ... ...
